A Study To Look At The Safety Of SB-681323 In Healthy Adult Subjects After Intravenous Administration Of A Single Dose
NCT00439881
·
clinicaltrials.gov ↗
PHASE1
Phase
COMPLETED
Status
16
Enrollment
INDUSTRY
Sponsor class
Conditions
Arthritis, Rheumatoid
Inflammation
Interventions
DRUG:
SB-681323
Sponsor
GlaxoSmithKline